e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Clinical aspects in the management of sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
QuantiFERON®-TB or QFT in sarcoidosis
K. A. Khan, M. Uzbeck, A. Collins, V. Twormey, A. O‘Regan (Galway, Ireland)
Source:
Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Session:
Clinical aspects in the management of sarcoidosis
Session type:
Thematic Poster Session
Number:
3452
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. A. Khan, M. Uzbeck, A. Collins, V. Twormey, A. O‘Regan (Galway, Ireland). QuantiFERON®-TB or QFT in sarcoidosis. Eur Respir J 2008; 32: Suppl. 52, 3452
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Evaluation of usefulness of QuantiFERON®-TB Gold for infants
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Outcome following an ²indeterminate² QuantiFERON®-TB gold test in suspected tuberculosis
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection
Source: Eur Respir J 2012; 40: 1443-1449
Year: 2012
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Comparison of QuantiFERON-TB Gold test and tuberculin skin test in diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 133s
Year: 2007
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017
The QuantiFERON-TB Gold test at HIV patients
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
The quantiferon testing and the diagnosis of tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Discordance QuantiFERON-TB Gold in-tube and tuberculin skin test: Latent tuberculosis infection or immunological memory?
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Importance of QuantiFERON-TB Gold and tuberculin skin test in the differential diagnosis of active and inactive pulmonary tuberculosis
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Utility of Quantiferon–TB Gold test in diagnosis of tuberculous pleural effusion
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Tuberculosis after a borderline QuantiFERON result during screening before infliximab
Source: Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018
Year: 2018
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept